Ardian

Key details

Profile type

Organization

Geography

Paris, Unknown / Other, France

Stage

4. Scaling, 5. Growth, 3. Early Revenue

Sector

biomarkers, sustainability, female, lesbian, second-generation, medicines, female led, inclusive, first generation, second generation, diversity, women's, women, social impact, in vitro diagnostics, drug, female-led, disabled, latinx, D&I, women-led, CGT, life sciences tools, black, female entrepreneur, lifescience, SDG, life science, latina, IVD, CBD, Sustainable Development Goals, pharmaceuticals, immigrants, underrepresented founders, Immigrant (1st or 2nd generation), life sciences, transcriptomics, female founded, therapeutics, genomics, female founders, social good, diverse, cell therapy, female founder, immigrant founders, psychedelics, underserved, mRNA, people of color, drugs, LGBT, social, psychedelic, protein, gene therapy, therapeutic, latino, underestimated founders, femtech, woman lead, African American, impact, first-generation, gay, proteomics, pharma, woman-lead, BIPOC, tech for good, biopharma, woman-led, bio, woman, overlooked teams, metabolites, woman led, biotech, immigrant, female-founded, inclusion, US Military Veteran, African-American, lifesciences, life-science, sustainable, historically ignored founder, metabolomics, cannabis, under-represented

Invests in

["Austria","Belgium","Canada","China","Denmark","France","Germany","Hungary","Italy","Japan","Latvia","Luxembourg","Singapore","Spain","Switzerland","Netherlands","UK","USA"]

Investment size

N/A

Founder groups

Not publicly stated